F.I.S.

Founded in 1957 in Montecchio Maggiore, Italy, and now backed by private equity fund Bain Capital, F.I.S. is a global CDMO leader in Europe for small-molecule active pharmaceutical ingredients and intermediates, employing over 2,300 people across three Italian sites plus offices in North America and Japan and operations in China and India. With more than 270 R&D specialists, the company offers integrated Custom, Generic, and R&D CDMO services spanning synthesis optimization, scale-up, and large-scale commercial manufacturing on an ODM basis. F.I.S. sells across North America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa, and is recognized for its established brand built over nearly seven decades of partnership with the world's leading pharmaceutical companies.